Based on recent data, Harrow Health, Inc. (HROW) shows an Average True Range (ATR) of 2.52 and an Enterprise Value of 479.59M. Its average trading volume over the past 3 months is 769.07K, indicating liquidity. These fundamental metrics provide insight into HROW's underlying financial health and market activity.
| ATR | 2.52 |
| Enterprise Value | 479.59M |
| Avg Vol (3 Months) | 769.07K |
| Avg Vol (10 Days) | 875.53K |
Harrow Health, Inc. (HROW) technical indicators as of June 23, 2026: the SMA 20 is 11.41%, SMA 50 at 12.28%, and SMA 200 at 36.43%. The RSI 14 value is 68.25, suggesting its current momentum. These technical analysis signals help assess HROW's price trends and potential future movements.
| SMA 20 | 11.41% |
| SMA 50 | 12.28% |
| SMA 200 | 36.43% |
| RSI 14 | 68.25 |
Harrow Health, Inc. (HROW) stock performance overview as of June 23, 2026: The 52-week high is $54.85 (currently -1.57% below), and the 52-week low is $28.54 (currently 158.94% above). Over the past year, HROW's performance is 42.62%, compared to the S&P 500's 10.67% change.
| 52-Week High | 54.85 |
| 52-Week High Chg | -1.57% |
| 52-Week Low | 28.54 |
| 52-Week Low Chg | +158.94% |
| S&P 500 52-Week Chg | 10.67% |
According to market data, Harrow Health, Inc. (HROW) stock's recent performance metrics show that over the last month, HROW is 7.5%, with a Year-to-Date (YTD) performance of -2.61%. Over the past year, the stock has seen a 42.62% change. These figures summarize HROW's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 44.5 | 44.5 | 44.5 | 54.85 | 54.85 | 54.85 |
| Low | 37.86 | 30.02 | 28.54 | 28.54 | 28.54 | 28.54 |
| Performance | -0.25% | +7.50% | +19.27% | +28.69% | +42.62% | -2.61% |
According to current financial data, HROW stock's P/E (TTM) ratio is -110.39, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for HROW, including P/S (6.01), P/B (56.20), and P/FCF (113.12), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | HROW | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -110.39 | -1.22 | 12.85 | 32.59 |
| P/S (TTM) | 6.01 | 3.69 | 6.17 | 5.98 |
| P/B (TTM) | 56.2 | 0.01 | 44.37 | 5 |
| P/FCF (TTM) | 113.12 | -10.32 | 3.79 | 28.32 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep